SERB
Location
ILE DE FRANCE
Founded
1951-07-25
Website
Risk Signals
29 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SERB
Live alerts from global media, monitored by Business Radar
2025-05-08 (thepostathens.com)
Faculty officially form union after SERB dismisses university objection - The Post
The United Academics of Ohio University officially unionized after the State Employment Relations Board dismissed the university's objection to the vote.
Read more
2025-05-07 (globenewswire.com)
Emergent BioSolutions Reports First Quarter 2025 Financial Results
First Quarter 2025 Total Revenues of $222.2 million, decrease of 26% versus prior yearFirst Quarter 2025 Net Income of $68.0 million, increase of 656%...
Read more
2025-04-23 (biotecnika.org)
NIPER Biotech & Life Sciences Research Fellow Recruitment – Apply Now
NIPER Biotech & Life Sciences Research Fellow Recruitment - Apply Now. NIPER Hyderabad Life Sciences Jobs. NIPER Biotech Jobs.
Read more
2025-04-18 (bakersfield.com)
SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 ... | News | .com
PLEASANTON, CA, March 29, 2025 (GLOBE NEWSWIRE) -- SFJ Pharmaceuticals (SFJ) and SERB Pharmaceuticals (SERB) announced today the final results of the pivotal Phase 3 REVERSE-IT trial designed to study
Read more
2025-04-16 (euronews.al)
Serb List: We Will Not Support Kurti's Vetëvendosje in Forming a New Government -
Serb List, the largest Kosovo Serb party backed by Belgrade, announced on Wednesday that it will not support acting Prime Minister Albin Kurti's Vetëvendosje movement in forming Kosovo's new government. In a Facebook statement, Serb List said that "claims made by Kurti's closest associates about alleged support from Serb List MPs are pure lies." "We […]
Read more
2025-04-02 (biotecnika.org)
Project Assistant Job Role at Amity University! MSc Life Science Apply Now
Project Assistant Job Role at Amity University! MSc Life Science NET Qualified Candidates Apply Now. SERB-funded research opportunity.
Read more
2025-01-09 (fiercepharma.com)
Catalyst settles with Teva, staving off Firdapse generic until 2035 |
Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med Firdapse, Catalyst Pharmaceutical has repeatedly emerged triumphant over its d | Thanks to a new settlement with Catalyst, Teva is barred from marketing its Firdapse generic in the U.S. until Feb. 25, 2035, at the earliest.
Read more
2025-01-08 (globenewswire.com)
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals
As Part of the Settlement, Teva Receives a License to Market Generic FIRDAPSE Beginning in February 2035...
Read more
2024-12-09 (globenewswire.com)
First FDA-approved treatment for severe frostbite now commercially available in the US
Philadelphia, PA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, is proud to announce that Aurlumyn™...
Read more
2024-10-21 (globenewswire.com)
SERB Pharmaceuticals expands leading emergency care portfolio with acquisition of Aurlumyn™ (iloprost IV) for severe frostbite
Philadelphia, PA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of...
Read more
2024-07-31 (globenewswire.com)
SERB Pharmaceuticals strengthens leadership in medical countermeasures with the global acquisition of RSDL® (Reactive Skin Decontamination Lotion) kit for $75 million
Philadelphia, PA, July 31, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of...
Read more
2024-05-30 (globenewswire.com)
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company's growth
Philadelphia, PA, May 30, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, has appointed Vanessa Wolfeler as its...
Read more